Bristol-Myers Squibb Company (BMY) · page 39 of 197
This slide is used by an activist investor to frame the CEO transition as a point of investor concern.
Activist deck · nominee_bio · introduce_nominees · dense density
Slide locked Sign in to view
Slide schematic 8/9
callout 1/2 image 1/1 list 2/2 paragraph 2/2 source-note 1/1 title 1/1
1 without position callout 1
callout
Components 9
primary callout headshot bullet bullet paragraph paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.